Gliclazide and Aplastic anemia - a phase IV clinical study of FDA data

Summary:

Aplastic anemia is reported as a side effect among people who take Gliclazide (gliclazide), especially for people who are male, 60+ old, also take Pantoprazole, and have Ischaemic stroke.

The phase IV clinical study analyzes which people have Aplastic anemia when taking Gliclazide. It is created by eHealthMe based on reports of 27,903 people who have side effects when taking Gliclazide from the FDA, and is updated regularly.

What is Gliclazide?

Gliclazide has active ingredients of gliclazide. It is often used in diabetes. eHealthMe is studying from 28,131 Gliclazide users. Check the latest studies of Gliclazide.

What is Aplastic anemia?

Aplastic anemia is found to be associated with 624 drugs and 880 conditions by eHealthMe. Check the latest studies of Aplastic anemia.

On Jul, 24, 2026

27,903 people reported to have side effects when taking Gliclazide.
Among them, 17 people (0.06%) have Aplastic anemia.

Among these 17 people:

What is the gender of people who have Aplastic anemia when taking Gliclazide? *

female: 13.33 %
male: 86.67 %

What is the age of people who have Aplastic anemia when taking Gliclazide? *

What are other drugs people take besides Gliclazide? *

What are other side effects people have besides Aplastic anemia? *

Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 9 people, 52.94%
Normochromic Normocytic Anaemia (forms of anaemia in which the average size and haemoglobin content of the red blood cells are within normal limits): 5 people, 29.41%
Osteoporosis (bones weak and more likely to break): 2 people, 11.76%
Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 2 people, 11.76%
Thrombocytopenia (decrease of platelets in blood): 1 person, 5.88%
Rib Fracture: 1 person, 5.88%
Dyspnea Exertional: 1 person, 5.88%
Abdominal Pain: 1 person, 5.88%

What are the existing conditions these people have? *

Ischaemic Stroke (stroke; caused by an interruption in the flow of blood to the brain): 9 people, 52.94%
High Blood Pressure: 6 people, 35.29%
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 5 people, 29.41%
Dyslipidaemia (abnormal amount of lipids): 5 people, 29.41%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 5 people, 29.41%
Paroxysmal Nocturnal Haemoglobinuria (haemoglobin in the urine): 2 people, 11.76%

* Approximation only. Some reports may have incomplete information.

Do you take Gliclazide and have Aplastic anemia?

- Check whether Aplastic anemia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Gliclazide:

Gliclazide (28,131 reports)

Aplastic anemia treatments and more:

Aplastic anemia (14,870 reports)

Browse all side effects of Gliclazide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Aplastic anemia:

Aplastic anemia (624 drugs)

Browse all the conditions that are associated with Aplastic anemia:

Aplastic anemia (880 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on gliclazide (the active ingredients of Gliclazide) and Gliclazide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.